Nature Reviews
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Nature Reviews
Feb 2, 2024, 12:20 |
Insight
Erman Akkus: Targeting p53 in cancer. Is it promising?
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Targeting p53 in cancer…
Jan 14, 2024, 10:02 |
Insight
Vivek Subbiah: Nature Reviews predicts a doubling of the incidence of all cancers combined by 2070 relative to 2020
Vivek Subbiah shared on LinkedIn: "Assuming that the latest incidence trends continue for the major…
Oct 2, 2023, 22:37 |
Insight
Paolo Tarantino: Antibody drug conjugates (ADCs) are leading to relevant survival improvements for multiple types of cancer.
Paolo Tarantino, MD and researcher at the European Institute of Oncology and clinical research fellow…
Jul 25, 2023, 14:23 |
Blog
Incredibly excited to see our article on optimizing the safety of ADCs making it to the cover of the August issue of Nature Reviews Clinical Oncology!
In a post by Paolo Tarantino on Twitter, it says, "Incredibly excited to see our…
All:
4
Posts:
1 - 100
TRANSiTION - Exclusive Train the Trainers Programme 2024
ASCO IDEA - Life-changing experience for the early-career oncologists in LMICs
Gemma Peters: The new government has an opportunity to fix our broken cancer care system
Blending Science and Compassion: Exclusive Conversation with ASCO President-Elect Eric J. Small
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Facebook
RSS Feed
Twitter
Linkedin
Youtube